Author

Kyobum Kim

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Polyaspartamide-Mediated Messenger RNA Delivery Enables Efficient Ex Vivo Engineering of Chimeric Antigen Receptor Natural Killer Cells via Enhanced Cellular Internalization.

Engineered natural killer (NK) cells expressing chimeric antigen receptor (CAR) represent a promising alternative to CAR T-cell therapy due to their allogeneic potential. However, current CAR NK cell production relies on lentiviral or retroviral transduction to achieve stable CAR expression, requiring complex, multiste...

Ha Yeon Park, Seon-Jeong Kim, Kyuree Kim et al. · ACS Applied Materials and In... · 0 citations

Review Aug 2026

Ex vivo live macrophage engineering strategies in immunotherapy.

Immune cell-based therapies have transformed immuno-oncology by converting living cells into therapeutic agents able to recognize, infiltrate, and eliminate diseased tissues. While T cell, NK cell, and dendritic cell platforms have delivered meaningful clinical advances, in solid tumors and chronically inflamed tissues...

Eunha Kim, Min-A Park, Kyobum Kim · Biotechnology Advances · 0 citations

#protein folding Open access Sep 2026

Harnessing the Folding of Antitumor Peptides for Controlled Carrier-Free Drug Delivery.

An antitumor peptide-based delivery platform in which both termini of a stapled p53 α-helix are linked via a disulfide bond, thereby repurposing nonpolar residues originally involved in target protein (hDM2) binding as a hydrophobic block that drives co-assembly with doxorubicin.

Jae Yun Lee, Moo Chang Park, Sung-Chan Choi et al. · Small · 0 citations